2021 Vol.39, N°4 - Table of contents
July-August
One year in review
CER14813
2021,39,4
Pg. 0705-0720
Free to view
One year in review 2021: novelties in the treatment of rheumatoid arthritis
E. Silvagni, G. Sakellariou, A. Bortoluzzi, A. Giollo, N. Ughi, L. Vultaggio, C.A. Scirè
DOI: https://doi.org/10.55563/clinexprheumatol/beucf1
E. Silvagni, G. Sakellariou, A. Bortoluzzi, A. Giollo, N. Ughi, L. Vultaggio, C.A. Scirè
DOI: https://doi.org/10.55563/clinexprheumatol/beucf1
Rapid paper
CER14566
2021,39,4
Pg. 0721-0726
Free to view
A multi-predictor model to predict risk of scleroderma renal crisis in systemic sclerosis: a multicentre, retrospective, cohort study
D. Xu, L. Zhu, R. Cai, Z. Yi, H. Zhang, G. Guo, S. Liu, J. Xu, Q. Wang, Y. Su, X. Li, J. Zhao, R. Mu
DOI: https://doi.org/10.55563/clinexprheumatol/sd1exj
D. Xu, L. Zhu, R. Cai, Z. Yi, H. Zhang, G. Guo, S. Liu, J. Xu, Q. Wang, Y. Su, X. Li, J. Zhao, R. Mu
DOI: https://doi.org/10.55563/clinexprheumatol/sd1exj
Full Papers
CER12991
2021,39,4
Pg. 0727-0735
The association of different serum IgG4 levels with distinct clinical characteristics and treatment efficacy in patients with IgG4-related disease
P. Zhang, Z. Liu, J. Li, Y. Fei, X. Wang, M. Wang, L. Zhu, H. Xue, R. Feng, C. Hu, S. Zhang, W. Zhang, Y. Zhao, X. Zeng, F. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/hbadoz
P. Zhang, Z. Liu, J. Li, Y. Fei, X. Wang, M. Wang, L. Zhu, H. Xue, R. Feng, C. Hu, S. Zhang, W. Zhang, Y. Zhao, X. Zeng, F. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/hbadoz
CER13179
2021,39,4
Pg. 0736-0745
Free to view
Direct costs in patients with chronic inflammatory arthropathies on biological therapy: a real-world data study
N. Martínez-López-De-Castro, M. Álvarez-Payero, M. Samartín-Ucha, C. Martínez-Reglero, A. Martín-Vila, M. Rodríguez-Rodríguez, G. Piñeiro-Corrales, J.F. Maceiras-Pan, R.B. Melero-González, J.M. Pego-Reigosa
DOI: https://doi.org/10.55563/clinexprheumatol/x1h3xi
N. Martínez-López-De-Castro, M. Álvarez-Payero, M. Samartín-Ucha, C. Martínez-Reglero, A. Martín-Vila, M. Rodríguez-Rodríguez, G. Piñeiro-Corrales, J.F. Maceiras-Pan, R.B. Melero-González, J.M. Pego-Reigosa
DOI: https://doi.org/10.55563/clinexprheumatol/x1h3xi
CER13221
2021,39,4
Pg. 0746-0752
Low-dose IL-2 effectively restored decreased regulatory T cells in patients with Behçet’s disease
X. Liu, W. Li, X. Liu, J. Luo, C. Gao, X. Li
DOI: https://doi.org/10.55563/clinexprheumatol/lnn76t
X. Liu, W. Li, X. Liu, J. Luo, C. Gao, X. Li
DOI: https://doi.org/10.55563/clinexprheumatol/lnn76t
CER13103
2021,39,4
Pg. 0753-0762
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons
I. Convertino, E. Lucenteforte, R. Gini, V. Lorenzoni, M. Cazzato, G. Turchetti, L. Trieste, S. Ferraro, L. Leonardi, G. Roberto, N. Luciano, C. Blandizzi, M. Mosca, M. Tuccori
DOI: https://doi.org/10.55563/clinexprheumatol/pa6lap
I. Convertino, E. Lucenteforte, R. Gini, V. Lorenzoni, M. Cazzato, G. Turchetti, L. Trieste, S. Ferraro, L. Leonardi, G. Roberto, N. Luciano, C. Blandizzi, M. Mosca, M. Tuccori
DOI: https://doi.org/10.55563/clinexprheumatol/pa6lap
CER13443
2021,39,4
Pg. 0763-0768
Free to view
Metformin repositioning in rheumatoid arthritis
Y. Matsuoka, S. Morimoto, M. Fujishiro, K. Hayakawa, Y. Kataoka, S. Suzuki, K. Ikeda, K. Takamori, K. Yamaji, N. Tamura
DOI: https://doi.org/10.55563/clinexprheumatol/zn2u9h
Y. Matsuoka, S. Morimoto, M. Fujishiro, K. Hayakawa, Y. Kataoka, S. Suzuki, K. Ikeda, K. Takamori, K. Yamaji, N. Tamura
DOI: https://doi.org/10.55563/clinexprheumatol/zn2u9h
CER13387
2021,39,4
Pg. 0769-0774
Free to view
Clinical efficacy of ultrasound-guided hyaluronic acid injections in patients with supraspinatus tendon tear
E. Cipolletta, R. Mashadi Mirza, A. Di Matteo, M. Di Carlo, W. Grassi, E. Filippucci
DOI: https://doi.org/10.55563/clinexprheumatol/cyiyy3
E. Cipolletta, R. Mashadi Mirza, A. Di Matteo, M. Di Carlo, W. Grassi, E. Filippucci
DOI: https://doi.org/10.55563/clinexprheumatol/cyiyy3
CER13473
2021,39,4
Pg. 0775-0780
HLA-B[*]27 is significantly enriched in Nordic patients with psoriatic arthritis mutilans
P. Nikamo, B. Gudbjornsson, L. Laasonen, L. Ejstrup, L. Iversen, U. Lindqvist, L. Padyukov, M. Ståhle
DOI: https://doi.org/10.55563/clinexprheumatol/aiams5
P. Nikamo, B. Gudbjornsson, L. Laasonen, L. Ejstrup, L. Iversen, U. Lindqvist, L. Padyukov, M. Ståhle
DOI: https://doi.org/10.55563/clinexprheumatol/aiams5
CER13018
2021,39,4
Pg. 0781-0789
Free to view
Three-year clinical outcomes in patients with rheumatoid arthritis treated with certolizumab pegol: results from the observational ECLAIR study
A. Saraux, B. Combe, F. Fagnani, G. Cukierman, I. Bru, J.-M. Joubert, J.-C. Schuller, J. Massol, R.-M. Flipo
DOI: https://doi.org/10.55563/clinexprheumatol/fkmsi2
A. Saraux, B. Combe, F. Fagnani, G. Cukierman, I. Bru, J.-M. Joubert, J.-C. Schuller, J. Massol, R.-M. Flipo
DOI: https://doi.org/10.55563/clinexprheumatol/fkmsi2
CER13543
2021,39,4
Pg. 0790-0794
Free to view
Trends in hospitalisations and inpatient mortality from acute myocardial infarction among patients with psoriatic arthritis: an analysis of nationwide inpatient sample 2004-2014
S. Jatwani, K. Jatwani, P. Tiwari, N. Wadhwa, K. Chugh
DOI: https://doi.org/10.55563/clinexprheumatol/kh5h6s
S. Jatwani, K. Jatwani, P. Tiwari, N. Wadhwa, K. Chugh
DOI: https://doi.org/10.55563/clinexprheumatol/kh5h6s
CER13391
2021,39,4
Pg. 0795-0803
Free to view
Clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sjögren’s syndrome
M. Mona, S. Mondello, J.Y. Hyon, W. Saleh, K. Han, H.-J. Lee, Y.-J. Ha, E.H. Kang, Y.J. Lee, S. Cha
DOI: https://doi.org/10.55563/clinexprheumatol/gy6udz
M. Mona, S. Mondello, J.Y. Hyon, W. Saleh, K. Han, H.-J. Lee, Y.-J. Ha, E.H. Kang, Y.J. Lee, S. Cha
DOI: https://doi.org/10.55563/clinexprheumatol/gy6udz
CER13288
2021,39,4
Pg. 0804-0810
Circulating TFH cells is correlated with disease activity in anti-MDA5 antibody positive idiopathic inflammatory myopathies
M. Zhou, M. Li, C. Guo, S. Wang, X. Li, S. Zhao, H. Zhang, N. Yang
DOI: https://doi.org/10.55563/clinexprheumatol/gfqlcz
M. Zhou, M. Li, C. Guo, S. Wang, X. Li, S. Zhao, H. Zhang, N. Yang
DOI: https://doi.org/10.55563/clinexprheumatol/gfqlcz
CER13493
2021,39,4
Pg. 0811-0818
Impact of a pharmacist-led programme on biologics knowledge and adherence in patients with spondyloarthritis
L. Gutermann, S. Dumas, C. Lopez-Medina, L. Boissinot, C. Cotteret, V. Perut, A. Molto, O. Conort, M. Dougados
DOI: https://doi.org/10.55563/clinexprheumatol/pzc5lo
L. Gutermann, S. Dumas, C. Lopez-Medina, L. Boissinot, C. Cotteret, V. Perut, A. Molto, O. Conort, M. Dougados
DOI: https://doi.org/10.55563/clinexprheumatol/pzc5lo
CER13343
2021,39,4
Pg. 0819-0828
Free to view
Are pain severity and current pharmacotherapies associated with quality of life, work productivity, and healthcare utilisation for people with osteoarthritis in five large European countries?
P.G. Conaghan, M.J. Doane, D.H. Jaffe, E. Dragon, L. Abraham, L. Viktrup, A.G. Bushmakin, J.C. Cappelleri, S. Perrot
DOI: https://doi.org/10.55563/clinexprheumatol/t5nm6l
P.G. Conaghan, M.J. Doane, D.H. Jaffe, E. Dragon, L. Abraham, L. Viktrup, A.G. Bushmakin, J.C. Cappelleri, S. Perrot
DOI: https://doi.org/10.55563/clinexprheumatol/t5nm6l
CER13031
2021,39,4
Pg. 0829-0837
Free to view
Systematic analysis of the molecular mechanisms of methotrexate therapy for rheumatoid arthritis using text mining
Q. Wang, Z. Fan, J. Li, L. Fu, L. Yan, B. Yang
DOI: https://doi.org/10.55563/clinexprheumatol/y562nj
Q. Wang, Z. Fan, J. Li, L. Fu, L. Yan, B. Yang
DOI: https://doi.org/10.55563/clinexprheumatol/y562nj
CER13567
2021,39,4
Pg. 0838-0843
Free to view
Increased eryptosis in patients with primary antiphospholipid syndrome (APS): a new actor in the pathogenesis of APS
M. Vomero, A. Finucci, C. Barbati, T. Colasanti, F. Ceccarelli, L. Novelli, L. Massaro, S. Truglia, C. Pensa, F.R. Mauro, R. Foà, G. Valesini, F. Conti, C. Alessandri
DOI: https://doi.org/10.55563/clinexprheumatol/8fx3u5
M. Vomero, A. Finucci, C. Barbati, T. Colasanti, F. Ceccarelli, L. Novelli, L. Massaro, S. Truglia, C. Pensa, F.R. Mauro, R. Foà, G. Valesini, F. Conti, C. Alessandri
DOI: https://doi.org/10.55563/clinexprheumatol/8fx3u5
CER13061
2021,39,4
Pg. 0844-0851
Interleukin-33 promotes proliferation and inhibits apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis
S. Wu, Y. Jiang, Y. Teng, X. Liu, L. Zhou, W. Li
DOI: https://doi.org/10.55563/clinexprheumatol/htpmp0
S. Wu, Y. Jiang, Y. Teng, X. Liu, L. Zhou, W. Li
DOI: https://doi.org/10.55563/clinexprheumatol/htpmp0
CER13375
2021,39,4
Pg. 0852-0858
Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data
G. Kimyon, U. Kalyoncu, S. Kiraz, C. Bes, N. Coşkun, B. Yağiz, O. Küçükşahin, N. Kanitez, A. Erden, L. Kiliç, E. Bilgin, T. Kaşifoğlu, H. Emmungil, S.S. Koca, S. Akar, M. Çinar, V. Yazisiz, A. Ateş, D. Ersözlü, E. Gönüllü, R. Mercan, İ. Ertenli
DOI: https://doi.org/10.55563/clinexprheumatol/jhpymv
G. Kimyon, U. Kalyoncu, S. Kiraz, C. Bes, N. Coşkun, B. Yağiz, O. Küçükşahin, N. Kanitez, A. Erden, L. Kiliç, E. Bilgin, T. Kaşifoğlu, H. Emmungil, S.S. Koca, S. Akar, M. Çinar, V. Yazisiz, A. Ateş, D. Ersözlü, E. Gönüllü, R. Mercan, İ. Ertenli
DOI: https://doi.org/10.55563/clinexprheumatol/jhpymv
CER13021
2021,39,4
Pg. 0859-0867
Endoplasmic reticulum stress perpetuated toll-like receptor signalling-mediated inflammation in rheumatoid arthritis via X-box-binding protein-1
F. Hu, Y. Tang, P. Wang, M. Bai, X. Li, J. Song, L. Shi, X. Sun, M. Jin, Z. Li, X. Li
DOI: https://doi.org/10.55563/clinexprheumatol/a7ehz7
F. Hu, Y. Tang, P. Wang, M. Bai, X. Li, J. Song, L. Shi, X. Sun, M. Jin, Z. Li, X. Li
DOI: https://doi.org/10.55563/clinexprheumatol/a7ehz7
CER13502
2021,39,4
Pg. 0868-0873
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study
G.M. Guidelli, O. Viapiana, N. Luciano, M. De Santis, N. Boffini, L. Quartuccio, D. Birra, E. Conticini, M.S. Chimenti, C. Bazzani, E. Bruschi, M. Riva, L.M. Canziani, G. Bianchi, M.R. Pozzi, M. Limonta, R. Gorla, R. Perricone, B. Frediani, P. Moscato, S. De Vita, L. Dagna, M. Rossini, C. Selmi
DOI: https://doi.org/10.55563/clinexprheumatol/pudtpo
G.M. Guidelli, O. Viapiana, N. Luciano, M. De Santis, N. Boffini, L. Quartuccio, D. Birra, E. Conticini, M.S. Chimenti, C. Bazzani, E. Bruschi, M. Riva, L.M. Canziani, G. Bianchi, M.R. Pozzi, M. Limonta, R. Gorla, R. Perricone, B. Frediani, P. Moscato, S. De Vita, L. Dagna, M. Rossini, C. Selmi
DOI: https://doi.org/10.55563/clinexprheumatol/pudtpo
CER14401
2021,39,4
Pg. 0874-0878
Free to view
Counselling patients for return to work on immunosuppression: practices of Canadian specialists during the COVID-19 pandemic
K. Ladak, K. Winthrop, J.K. Marshall, J. Gelfand, J. Pope
DOI: https://doi.org/10.55563/clinexprheumatol/9ysvg3
K. Ladak, K. Winthrop, J.K. Marshall, J. Gelfand, J. Pope
DOI: https://doi.org/10.55563/clinexprheumatol/9ysvg3
Brief Paper
CER14341
2021,39,4
Pg. 0879-0882
Free to view
Rheumatoid arthritis autoantibodies and their association with age and sex
E. Pertsinidou, V.A. Manivel, H. Westerlind, L. Klareskog, L. Alfredsson, L. Mathsson-Alm, M. Hansson, S. Saevarsdottir, J. Askling, J. Rönnelid
DOI: https://doi.org/10.55563/clinexprheumatol/4bcmdb
E. Pertsinidou, V.A. Manivel, H. Westerlind, L. Klareskog, L. Alfredsson, L. Mathsson-Alm, M. Hansson, S. Saevarsdottir, J. Askling, J. Rönnelid
DOI: https://doi.org/10.55563/clinexprheumatol/4bcmdb
Reviews
CER13424
2021,39,4
Pg. 0883-0888
Free to view
Imaging in polymyalgia rheumatica: which technique to use?
F.A. Figus, M. Skoczyńska, R. Mcconnell, G. Massazza, A. Iagnocco
DOI: https://doi.org/10.55563/clinexprheumatol/5qmpcb
F.A. Figus, M. Skoczyńska, R. Mcconnell, G. Massazza, A. Iagnocco
DOI: https://doi.org/10.55563/clinexprheumatol/5qmpcb
CER13930
2021,39,4
Pg. 0889-0898
The modulatory roles of T cell glycosylation in systemic lupus erythematosus
Y. Long, C. Hu, X. Zeng
DOI: https://doi.org/10.55563/clinexprheumatol/souulk
Y. Long, C. Hu, X. Zeng
DOI: https://doi.org/10.55563/clinexprheumatol/souulk
CER14109
2021,39,4
Pg. 0899-0906
Gastrointestinal and hepatic involvement in paediatric systemic lupus erythematosus
S. Trapani, C. Rubino, G. Simonini, G. Indolfi
DOI: https://doi.org/10.55563/clinexprheumatol/oebrcq
S. Trapani, C. Rubino, G. Simonini, G. Indolfi
DOI: https://doi.org/10.55563/clinexprheumatol/oebrcq
Paediatric Rheumatology
CER13904
2021,39,4
Pg. 0907-0912
Drug survival of the infliximab biosimilar (CT-P13) in paediatric patients with non-infectious uveitis
B. Sözeri, E. Kardeş, E. Salı, D. Çakır, F. Demir
DOI: https://doi.org/10.55563/clinexprheumatol/r4gnxm
B. Sözeri, E. Kardeş, E. Salı, D. Çakır, F. Demir
DOI: https://doi.org/10.55563/clinexprheumatol/r4gnxm
CER14282
2021,39,4
Pg. 0913-0919
A prediction rule for polyarticular extension in oligoarticular-onset juvenile idiopathic arthritis
B. Schiappapietra, C. Bava, S. Rosina, A. Pistorio, F. Mongelli, S. Pederzoli, S. Verazza, S. Lanni, V. Muratore, S. Davì, S. Dalprà, G.C. Varnier, M. Bertamino, C. Suffia, G. Bracciolini, G. Giancane, A. Consolaro, A. Ravelli
DOI: https://doi.org/10.55563/clinexprheumatol/uxnm7j
B. Schiappapietra, C. Bava, S. Rosina, A. Pistorio, F. Mongelli, S. Pederzoli, S. Verazza, S. Lanni, V. Muratore, S. Davì, S. Dalprà, G.C. Varnier, M. Bertamino, C. Suffia, G. Bracciolini, G. Giancane, A. Consolaro, A. Ravelli
DOI: https://doi.org/10.55563/clinexprheumatol/uxnm7j
Letters to the Editor
CER14360
2021,39,4
Pg. 0920
Free to view
Calcium pyrophosphate disease and polymyalgia reumatica: association or coincidence? Comment on “Ultrasound shoulder assessment of calcium pyrophosphate disease with suspected polymyalgia rheumatica” Ottaviani et al.
M. Milchert, C. Manzo, A. Castagna, M. Brzosko
DOI: https://doi.org/10.55563/clinexprheumatol/kcan9r
M. Milchert, C. Manzo, A. Castagna, M. Brzosko
DOI: https://doi.org/10.55563/clinexprheumatol/kcan9r
CER14391
2021,39,4
Pg. 0921
Free to view
Reply to: Calcium pyrophosphate disease and polymyalgia rheumatica: association or coincidence?
S. Ottaviani
DOI: https://doi.org/10.55563/clinexprheumatol/f1eqjx
S. Ottaviani
DOI: https://doi.org/10.55563/clinexprheumatol/f1eqjx
CER14118
2021,39,4
Pg. 0922-0923
Free to view
Sexual disinterest among spondyloarthritis patients. Comparison between psoriatic arthritis and axial spondyloarthritis using a sexuality-specific question from the ASAS Health Index
R. Queiro, S. Alonso, I. Morante, M. Alperi
DOI: https://doi.org/10.55563/clinexprheumatol/d1hvl1
R. Queiro, S. Alonso, I. Morante, M. Alperi
DOI: https://doi.org/10.55563/clinexprheumatol/d1hvl1
CER14229
2021,39,4
Pg. 0924
Free to view
Retinal detachment as the first manifestation of systemic lupus erythematosus
B. Iaccheri, A. Cerquaglia, E. Bartoloni, C. Cagini, T. Fiore
DOI: https://doi.org/10.55563/clinexprheumatol/8skas6
B. Iaccheri, A. Cerquaglia, E. Bartoloni, C. Cagini, T. Fiore
DOI: https://doi.org/10.55563/clinexprheumatol/8skas6
CER14379
2021,39,4
Pg. 0925-0926
Free to view
Relative increase of Th17 phenotype in senescent CD4+CD28null T cells from peripheral blood of patients with rheumatoid arthritis
M. Patlán, A. Páez, F. Massó, L.M. Amezcua-Guerra
DOI: https://doi.org/10.55563/clinexprheumatol/q8xvkl
M. Patlán, A. Páez, F. Massó, L.M. Amezcua-Guerra
DOI: https://doi.org/10.55563/clinexprheumatol/q8xvkl